drugset / Trial / NCT00077207

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

NCT00077207

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as carboplatin, vincristine, and temozolomide, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving more than one drug may kill more tumor cells. PURPOSE: This pilot study is studying giving carboplatin and vincristine together with temozolomide in treating children with progressive and/or symptomatic low-grade glioma.

Timeline

Start
2004-07
Primary completion
2010-03
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 175 unknown Intravenous
Subject Temozolomide Small molecule 200 mg/m2 Oral
Subject Vincristine Small molecule 1.5 mg/m2 Intravenous

Indications